SEC Form 4 · accession 0001019687-15-001090
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Allen Wolff
Officer — CFO
Period of report
Mar 23, 2015
Accepted (ET)
Mar 25, 2015 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $0.55 | Mar 23, 2015 | A | 500,000 | A | Mar 23, 2016 | Mar 22, 2025 | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1Stock option granted under the NTN Buzztime, Inc. 2010 Plan. The stock option shall vest and become exercisable at the rate of 25% of the shares underlying the option on the first anniversary of the option grant date and the remaining 75% of the total number of shares of common stock shall become vested and exercisable in a series of 36 substantially equal monthly installments thereafter.